Managing the Risks and Challenges of Syringe Processing (E05)
Current as of 21 January 2010
Planned and Implemented by the ISPE SPP Community of Practice (COP)
Attend this seminar for global case studies and interactive workshops on the recent technologies and solutions.
From the initial decision on which syringes to process — bulk syringes or presterilized syringes in tubs — to the latest inspection systems and laser marking technology, this seminar will present the latest technologies and trends in many aspects of syringe processing. Whether you are in clinical operations or highvolume pharmaceuticals and biologicals, have existing operations, or are starting new ones, this seminar will provide information and practical implications that can improve quality and increase productivity.
With syringe filling growing, many companies are either starting syringe operations or increasing their throughput. It is estimated that there are over 2 billion syringes processed annually now. Technologies surround syringe processing operations and are improving with new and improved equipment and solutions.
Case studies and working sessions will examine the risks and challenges surrounding syringe processing.
How You Will Benefit
At the conclusion of this session, participants will be able to:
- Analyze technologies to improve syringe operations
- Effectively manage risk
- Solve manufacturing challenges
- Implement effective commissioning and qualification practices
- Strengthen supply chain security with newly available technologies
Who Should Attend
Professionals in syringe technology of any type, as well as those from quality assurance, quality control, C&Q, maintenance, engineering, supply chain, materials management, product development, clinical operations, contract manufacturing, and outsourcing to a contract manufacturer
- Jeff Campie, USA
- Richard Forsyth, Senior Consultant, Hyde Engineering + Consulting, USA
- Nigel Hamilton, Global Quality, Strategy and Process Excellence, Sanofi Aventis, United Kingdom
- Aisling Horan, Validation Scientist, Alkermes Plc, Ireland
- Edwin Melendez, Principle Consultant, Parexel, USA
- Mark O'Reilly, Director Engineering, Alkermes Pharma Ireland Ltd, Ireland
- Kimberly Ray, A. Director Project Mgmt, Oso Biopharmaceuticals Mfg LLC, USA
- Julian Wilkins, Vice President, PharmaConsult US Inc, USA
- Paul Wreglesworth, Independent Consultant, United Kingdom
Communities of Practice (COPs)
Sterile Products Processing
CPIP™ Knowledge Elements
This Webinar relates to the following CPIP™ Knowledge Elements:
ISPE will provide continuing education units (ISPE CEUs) for all North American seminars and courses, including educational programming at the ISPE Annual Meeting. CEUs are nationally recognized units of achievement designed for those individuals continuing their education in their chosen field or profession.
Delegates attending European seminars and courses will receive a Certificate of Attendance, as ISPE CEUs are currently not offered at European events. Verification of CEUs is based on attendance as well as satisfactory completion of all evaluation materials. Statements of credit will be sent via email within four weeks of evaluation materials. One hour of education programming equals 0.1 ISPE CEU credits.